Institutional Ownership Verona Pharma PLC (VRNA)
This table provides information about the institutional ownership of Verona Pharma PLC (VRNA). We have compiled data on the 218 institutions that hold shares in the stock, with a total of 70.5 Million shares, which have been reported (via 13F filing form) to have a value of $4.65 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
6,392,106
shares
|
$431 Million
9.9% of portfolio
|
Q4 2024
Added 1.21%
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
5,584,753
shares
|
$377 Million
18.53% of portfolio
|
Q2 2024
Added 9.32%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
3,383,950
shares
|
$228 Million
9.42% of portfolio
|
Q3 2024
Added 2.1%
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,132,127
shares
|
$211 Million
2.79% of portfolio
|
Q4 2024
Added 29.11%
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Feb 14, 2025 Q4 2024 |
3,128,516
shares
|
$211 Million
2.81% of portfolio
|
Q4 2024
Reduced 25.79%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,025,241
shares
|
$204 Million
0.03% of portfolio
|
Q4 2024
Added 61.03%
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,457,500
shares
|
$166 Million
21.3% of portfolio
|
Q2 2022
Added 0.0%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
2,283,975
shares
|
$154 Million
20.7% of portfolio
|
Q4 2024
Reduced 35.66%
|
|
Summit Partners Public Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,902,026
shares
|
$128 Million
2.14% of portfolio
|
Q4 2024
New holding
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
1,889,542
shares
|
$128 Million
0.05% of portfolio
|
Q4 2024
Added 8.54%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,833,532
shares
|
$124 Million
0.01% of portfolio
|
Q4 2024
Added 37.32%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
1,825,293
shares
|
$123 Million
0.2% of portfolio
|
Q4 2024
Reduced 15.8%
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,821,019
shares
|
$123 Million
1.38% of portfolio
|
Q4 2024
New holding
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,766,830
shares
|
$119 Million
1.33% of portfolio
|
Q4 2024
Reduced 64.73%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,667,165
shares
|
$113 Million
0.04% of portfolio
|
Q4 2024
Added 59.87%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
1,485,256
shares
|
$100 Million
1.19% of portfolio
|
Q4 2024
Added 3.58%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,483,753
shares
|
$100 Million
0.0% of portfolio
|
Q4 2024
Added 151.1%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,352,713
shares
|
$91.3 Million
0.01% of portfolio
|
Q4 2024
Added 14.83%
|
|
Aisling Capital Management LP
New York, NY |
Feb 12, 2025 Q4 2024 |
1,115,352
shares
|
$75.3 Million
18.98% of portfolio
|
Q1 2023
Reduced 16.3%
|
|
Foresite Capital Management Iii, LLC
Larkspur, CA |
Nov 14, 2022 Q3 2022 |
1,111,112
shares
|
$75 Million
29.98% of portfolio
|
Q1 2021
New holding
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
1,079,555
shares
|
$72.9 Million
0.06% of portfolio
|
Q4 2024
Reduced 2.84%
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
954,616
shares
|
$64.4 Million
2.68% of portfolio
|
Q4 2024
Reduced 3.09%
|
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
887,580
shares
|
$59.9 Million
1.11% of portfolio
|
Q4 2024
Added 29.38%
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
850,000
shares
|
$57.4 Million
1.74% of portfolio
|
Q4 2024
Reduced 73.27%
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
Feb 14, 2025 Q4 2024 |
810,449
shares
|
$54.7 Million
3.56% of portfolio
|
Q4 2024
New holding
|